The first randomized controlled trial to compare two lung volume reduction procedures for people with emphysema has found that both lead to similar improvements in lung function, breathlessness and exercise capacity.
Sep 6, 2022
0
7
Investigators report on three-year follow-up of superficial BCC patients treated topically with non-surgical, noninvasive therapies in the Journal of Investigative Dermatology
Jun 2, 2016
0
11
In one of the first studies to look at transcranial magnetic stimulation (TMS) in real-world clinical practice settings, researchers at Butler Hospital, along with colleagues across the U.S., confirmed that TMS is an effective ...
Jul 26, 2012
0
1
In utero exposure to commonly prescribed antipsychotic medications does not seem to meaningfully increase the risk for neurodevelopmental disorders (NDD) in offspring, according to a study published online March 28 in JAMA ...
Mar 31, 2022
0
17
For the approximately 8.5 million people in the U.S. living with peripheral artery disease (PAD—pronounced P-A-D), which is narrowed or clogged arteries in the legs, treatment decisions and criteria for success should be ...
Oct 13, 2022
0
8
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that there is currently insufficient evidence to weigh the benefits and harms of use of the ankle-brachial index (ABI) for screening for peripheral ...
Sep 3, 2013
0
0
Social networking sites like Facebook and YouTube can be powerful platforms to deliver and receive healthcare information, especially for patients and caregivers who are increasingly going online to connect and share experiences ...
Oct 31, 2011
0
0
In the United States, turning 45 brings with it a rather unpleasant rite of passage: the beginning of regular colonoscopies, in which an endoscope equipped with a light and a camera is used to visually check the colon for ...
Jan 19, 2023
0
35
Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna has investigated the extent to which diagnosis and therapy ...
Oct 23, 2023
0
57
The prognosis for patients with stage II and III inoperable non-small cell lung cancer (NSCLC) is poor, with only about 15 percent of patients surviving at five years post-treatment for the disease. While new treatment strategies ...
Oct 5, 2011
0
0
